Deficiency of m6A RNA methylation promotes ZBP1-mediated cell death
Shuang LiiD, Xiangyu DengiD, Deepak Pathak, Rashmi Basavaraj, Lina Sun, Yating Cheng, Jianrong LiiD, Marissa Burke, Gavin Wayne BritziD, Chao ChengiD, Yang GaoiD, Yi‐Lan WengiD
Abstract
m6A RNA methylation suppresses the immunostimulatory potential of endogenous RNA. Deficiency of m6A provokes inflammatory responses and cell death, but the underlying mechanisms remain elusive. Here we showed that the noncoding RNA 7SK gains immunostimulatory potential upon m6A depletion and subsequently activates the RIG-I/MAVS axis to spark interferon (IFN) signaling cascades. Concomitant excess of IFN and m6A deficiency synergistically facilitate the formation of RNA G-quadruplexes (rG4) to promote ZBP1-mediated necroptotic cell death. Collectively, our findings delineate a hitherto uncharacterized mechanism that links m6A dysregulation with ZBP1 activity in triggering inflammatory cell death.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ZBP1 Senses Splicing Aberration through Z-RNA to promote Cell Death
Zhang-Hua Yang, Puqi Wu, … Wei Mo·Molecular CellPeer-reviewed·Apr 22, 2025
- A ZBP1 isoform blocks ZBP1-mediated cell death
Zhi-Yu Cai, Puqi Wu, … Zhang-Hua Yang·bioRxiv·Feb 2, 2024
- The mitochondrial RNA extrusion-induced innate immunity is regulated by N6-methyladenosine machinery
Qing Hu, Yifei Zhang, … Mijia Lu·bioRxiv·Sep 2, 2026
- The RNA binding protein, HNRNPA2B1, regulates IFNG signaling in macrophages
M. Mohammed Salih, C. G. Weindel, … S. Carpenter·bioRxiv·Oct 12, 2023
- Cellular RNA interacts with MAVS to promote antiviral signaling
N. S. Gokhale, K. Somfleth, … R. Savan·bioRxiv·Sep 25, 2023
- The RNA m6A reader YTHDF2 controls NK cell anti-tumor and anti-viral immunity